We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
-1.2%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$16.9B
AUM Growth
-$468M
(-2.7%)
Cap. Flow
+$68M
Cap. Flow
% of AUM
0.4%
Top 10 Holdings %
Top 10 Hldgs %
22.54%
Holding
1,101
New
144
Increased
331
Reduced
453
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$319M |
| 2 |
Uber
UBER
|
+$90.8M |
| 3 |
Tyson Foods
TSN
|
+$81.8M |
| 4 |
Archer Daniels Midland
ADM
|
+$81.5M |
| 5 |
Travelers Companies
TRV
|
+$81.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Altria Group
MO
|
+$106M |
| 2 |
Lockheed Martin
LMT
|
+$88.6M |
| 3 |
Ross Stores
ROST
|
+$77.9M |
| 4 |
Hilton Worldwide
HLT
|
+$69.3M |
| 5 |
Cigna
CI
|
+$58.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.51% |
| 2 | Financials | 12.87% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 12.35% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NFBK
851
DELISTED
Northfield Bancorp
NFBK
| $374K | ﹤0.01% |
39,621
+27,274
| +221% | +$298K |
|
852
Instil Bio
TIL
$49.4M
| $371K | ﹤0.01% |
43,364
+32,677
| +306% | +$329K |
|
853
Morningstar
MORN
$7.38B
| $370K | ﹤0.01% |
1,579
-6,222
| -80% | -$1.4M |
|
|
KZR
854
DELISTED
Kezar Life Sciences
KZR
| $367K | ﹤0.01% |
30,858
-29,469
| -49% | -$522K |
|
855
Nkarta
NKTX
$159M
| $366K | ﹤0.01% |
263,274
| – | – |
|
856
Nabors Industries
NBR
$1.12B
| $365K | ﹤0.01% |
2,965
| – | – |
|
857
LegalZoom.com
LZ
$1.39B
| $356K | ﹤0.01% |
32,525
-702,259
| -96% | -$8.61M |
|
858
Harvard Bioscience
HBIO
$26.7M
| $356K | ﹤0.01% |
8,274
-1,490
| -15% | -$68.8K |
|
859
Park-Ohio Holdings
PKOH
$564M
| $356K | ﹤0.01% |
+17,856
| New | +$337K |
|
860
NovoCure
NVCR
$1.89B
| $355K | ﹤0.01% |
+21,962
| New | +$633K |
|
861
Inseego
INSG
$111M
| $354K | ﹤0.01% |
+84,334
| New | +$525K |
|
862
Karat Packaging
KRT
$832M
| $352K | ﹤0.01% |
+15,253
| New | +$327K |
|
863
EyePoint Inc
EYPT
$1B
| $350K | ﹤0.01% |
43,761
| – | – |
|
|
DMC
864
Del Monte Corp
DMC
$1.37B
| $347K | ﹤0.01% |
13,414
-13,697
| -51% | -$358K |
|
865
Century Therapeutics
IPSC
$370M
| $343K | ﹤0.01% |
171,282
-11,942
| -7% | -$31.8K |
|
866
Pixelworks
PXLW
$37.2M
| $335K | ﹤0.01% |
24,728
-16,147
| -40% | -$279K |
|
|
AVID
867
DELISTED
Avid Technology Inc
AVID
| $335K | ﹤0.01% |
12,455
-368,448
| -97% | -$9.69M |
|
868
Community Health Systems
CYH
$393M
| $313K | ﹤0.01% |
107,762
-413,039
| -79% | -$1.53M |
|
869
Bunge Global
BG
$22.8B
| $312K | ﹤0.01% |
2,881
| – | – |
|
870
Vertiv
VRT
$104B
| $311K | ﹤0.01% |
8,365
-659,194
| -99% | -$21.7M |
|
871
Roblox
RBLX
$35.4B
| $310K | ﹤0.01% |
10,718
-6,522
| -38% | -$217K |
|
872
Citigroup
C
$222B
| $309K | ﹤0.01% |
+7,523
| New | +$330K |
|
873
Hippo Holdings
HIPO
$789M
| $309K | ﹤0.01% |
+38,800
| New | +$488K |
|
874
Johnson Controls International
JCI
$85.6B
| $304K | ﹤0.01% |
5,715
+1,652
| +41% | +$102K |
|
875
Zevra Therapeutics
ZVRA
$575M
| $302K | ﹤0.01% |
+62,575
| New | +$312K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2023 Portfolio in Review
As of Q3 2023, Jacobs Levy Equity Management held 1,101 positions worth $16.9B, down 2.7% from $17.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jacobs Levy Equity Management's Q3 2023 filing shows 144 new, 331 increased, 453 reduced and 149 closed positions. Its largest new stake was Tyson Foods: 1,536,421 shares worth $77.6M. The largest sale was Altria Group, an estimated $106M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Financials and Healthcare.
- Jacobs Levy Equity Management's largest Q3 2023 buy was Tyson Foods: 1,536,421 shares worth $77.6M.
- Jacobs Levy Equity Management added most to NVIDIA in Q3 2023, an estimated $319M increase.
- Jacobs Levy Equity Management's biggest Q3 2023 reduction was Altria Group, cutting an estimated $106M.
- Jacobs Levy Equity Management fully exited Hilton Worldwide in Q3 2023, selling an estimated $69.3M.
- Jacobs Levy Equity Management's ten largest holdings make up 23% of its $16.9B portfolio in Q3 2023.
- Jacobs Levy Equity Management opened 144 new positions and closed 149 in Q3 2023.
- Jacobs Levy Equity Management's portfolio value fell 2.7% quarter-over-quarter to $16.9B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2023, filed 17 Nov 2023.